FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine and concerns a therpaeutic composition of antituberculous preparations with a phospholipid transport system consisting of fatty acid salt, herbal phosphatidylcholine (73-94%), maltose and an antituberculous agent specified in rifamycin, protionamide, rifabutin and rifapentine, and method for preparing it.
EFFECT: composition possess higher antitubeculous activity.
3 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF NANOPHOSPHOLIPID COMPOSITION OF RIFAMPICINE TOGETHER WITH PROTIONAMIDE OR ITS NANOPHOSPHOLIPID FORM IN TREATMENT OF TUBERCULOSIS | 2014 |
|
RU2595881C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545903C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE WITH COMPLEXANT FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545902C1 |
| COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
| COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
| ANTITUMOUR AGENT FOR TREATING PROSTATE CANCER IN THE FORM OF SACHET | 2018 |
|
RU2695326C1 |
| PHARMACEUTICAL COMPOSITION AND KIT FOR TREATING BACTERIAL INFECTIONS | 2011 |
|
RU2496475C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
| METHOD FOR PREPARING HIGH-BIOAVAILABILITY RIFABUTIN COMPOSITION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MYCOBACTERIOSIS | 2013 |
|
RU2520603C1 |
